Metraipolis › archive › dc_586b0ccf05c8

Validation of a De Novo Health Economic Model for Finerenone in Heart Failure with Left Ventricular Ejection Fraction ≥40 — Europe PMC PMID:41892985

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41892985
DOI: 10.3390/jmahp14010016
License (as archived): solo-consultazione
Archived: 2026-11-04T13:00:23.114Z
SHA-256 of the archived text: 19e4567389ca35ab88f219aaca7d2a295b49b7f62b96e3eb6ae228ef4d2265ae
Stable URL of this page: https://metraipolis.com/documento/dc_586b0ccf05c8

How to cite

Validation of a De Novo Health Economic Model for Finerenone in Heart Failure with Left Ventricular Ejection Fraction ≥40 — Europe PMC PMID:41892985 — Europe PMC (en), https://europepmc.org/article/MED/41892985 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_586b0ccf05c8 (Metraipolis archive dc_586b0ccf05c8, sha256 19e4567389ca35ab88f219aaca7d2a295b49b7f62b96e3eb6ae228ef4d2265ae)

BibTeX

@misc{dc586b0ccf05c8,
  title = {Validation of a De Novo Health Economic Model for Finerenone in Heart Failure with Left Ventricular Ejection Fraction ≥40 — Europe PMC PMID:41892985},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41892985},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_586b0ccf05c8; sha256 19e4567389ca35ab88f219aaca7d2a295b49b7f62b96e3eb6ae228ef4d2265ae},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41892985. Agents can read the archived copy with the MCP tool read_document.